Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China

World Journal of Gastroenterology

Volumn 19, Issue 30, 2013, Pages 4984-4991

  Wang, Ji Yao ^a   Zhang, Ning Ping ^a   Chi, Bao Rong ^b   Mi, Yu Qing ^c   Meng, Li Na ^d   Liu, Ying Di ^e   Wang, Jiang Bin ^f   Jiang, Hai Xing ^g   Yang, Jin Hui ^h   Xu, Yun ⁱ   Li, Xiao ^j   Xu, Jian Ming ^k   Zhang, Guo ^l   Zhou, Xin Min ^m   Zhuge, Yu Zheng ⁿ   Tian, De An ^o   Ye, Jin ^o   Liu, Yu Lan ^p  

^a FUDAN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c Tianjin Infectious Disease Hospital   (China)

^d ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

^f JILIN UNIVERSITY   (China)

^g FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^h KUNMING MEDICAL UNIVERSITY   (China)

ⁱ THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^j SICHUAN UNIVERSITY   (China)

^k ANHUI MEDICAL UNIVERSITY   (China)

^l PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^m FOURTH MILITARY MEDICAL UNIVERSITY   (China)

ⁿ MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^o HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^p PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

more..

Author keywords

Child Pugh Classification; China; Healthrelated quality of life; Liver cirrhosis; Minimal hepatic encephalopathy

Indexed keywords

ALBUMIN; BILIRUBIN; HEPATITIS B (E) ANTIGEN; POTASSIUM ION; SODIUM ION; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGE; AGED; ARTICLE; ASCITES; CHILD PUGH SCORE; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; THROMBOCYTE COUNT;

EID: 84881538692     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i30.4984     Document Type: Article

References (40)

1. Mullen KD, Prakash RK. New perspectives in hepatic encephalopathy. Clin Liver Dis 2012; 16: 1-5 [PMID: 22321461 DOI: 10.1016/j. cld.2012.01.001]
2. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-2723 [PMID: 11569701]
3. Kharbanda PS, Saraswat VA, Dhiman RK. Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods. Indian J Gastroenterol 2003; 22 Suppl 2: S37-S41 [PMID: 15025253]
4. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10: 239-248 [PMID: 8830284 DOI: 10.1007/ BF02081029]
5. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essinkbot ML, Hop WC, Schalm SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-49 [PMID: 9657095 DOI: 10.1002/hep.510280108]
6. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-559 [PMID: 17326150 DOI: 10.1002/hep.21533]
7. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721 [PMID: 11870389 DOI: 10.1053/jhep.2002.31250]
8. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis 1996; 16: 321-328 [PMID: 8989817 DOI: 10.1055/s-2007-1007244]
9. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24: 556-560 [PMID: 8781324 DOI: 10.1002/hep.510240316]
10. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-535 [PMID: 11350549 DOI: 10.1046/j.1440-1746.2001.02487. x]
11. Amodio P, Quero JC, Del Piccolo F, Gatta A, Schalm SW. Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG. Metab Brain Dis 1996; 11: 315-327 [PMID: 8979251 DOI: 10.1007/BF02029493]
12. Li YY, Nie YQ, Sha WH, Zeng Z, Yang FY, Ping L, Jia L. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10: 2397-2401 [PMID: 15285027]
13. Lin Y, Fan YP. [The neuropsychologic tests and the minimal hepatic encephalopathy investigations in liver cirrhotic patients]. Zhonghua Ganzangbing Zazhi 2011; 19: 65-66 [PMID: 21272466 DOI: 10.3760/cma.j. issn.1007-3418.2011.01.020]
14. Bao ZJ, Ma X, Qiu DK. [Methods for diagnosis of minimal hepatic encephalopathy and their evaluation]. Zhonghua Ganzangbing Zazhi 2005; 13: 878-880 [PMID: 16313750]
15. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-178 [PMID: 11208726 DOI: 10.1053/gast.2001.21193]
16. Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003; 48: 1622-1626 [PMID: 12924658]
17. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 37-41 [PMID: 11726087]
18. Zhou YQ, Chen SY, Jiang LD, Guo CY, Shen ZY, Huang PX, Wang JY. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol 2009; 24: 408-415 [PMID: 19054261 DOI: 10.1111/ j.1440-1746.2008.05678. x]
19. Bao ZJ, Qiu DK, Ma X, Zhang GS, Gu T, Yu XF, Fan ZP, Li JQ, Zeng MD. The application of psychometric measures in diagnosis of minimal hepatic encephalopathy. Zhonghua Xiaohua Zazhi 2006; 26: 606-609
20. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851 [PMID: 18328931 DOI: 10.1016/S0140-6736(08)60383-9]
21. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538 [PMID: 16879891 DOI: 10.1016/ j. jhep.2006.05.013]
22. Zeng Z, Li YY, Nie YQ. [An epidemiological survey of subclinical hepatic encephalopathy]. Zhonghua Ganzangbing Zazhi 2003; 11: 680-682 [PMID: 14636446]
23. Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000; 45: 1549-1552 [PMID: 11007104]
24. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-1449 [PMID: 15122774 DOI: 10.1002/ hep.20194]
25. Senzolo M, Amodio P, D'Aloiso MC, Fagiuoli S, Del Piccolo F, Canova D, Masier A, Bassanello M, Zanus G, Burra P. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation. Transplant Proc 2005; 37: 1104-1107 [PMID: 15848636 DOI: 10.1016/j. transproceed.2004.12.265]
26. Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol 2010; 25: 1029-1041 [PMID: 20594216 DOI: 10.1111/j.1440-1746.2010.06318. x]
27. McKenzie DP, Mackinnon AJ, Péladeau N, Onghena P, Bruce PC, Clarke DM, Harrigan S, McGorry PD. Comparing correlated kappas by resampling: is one level of agreement significantly different from another? J Psychiatr Res 1996; 30: 483-492 [PMID: 9023792 DOI: 10.1016/ S0022-3956(96)00033-7]
28. Thompson WD, Walter SD. A reappraisal of the kappa coefficient. J Clin Epidemiol 1988; 41: 949-958 [PMID: 3057117 DOI: 10.1016/0895-4356(88)90031-5]
29. Blackman NJ, Koval JJ. Interval estimation for Cohen's kappa as a measure of agreement. Stat Med 2000; 19: 723-741 [PMID: 10700742]
30. Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42 Suppl: S45-S53 [PMID: 15777572]
31. Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000; 32: 748-753 [PMID: 10845661 DOI: 10.1016/S0168-8278(00)80243-3]
32. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-267 [PMID: 15554421]
33. Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY. Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011; 33: 739-747 [PMID: 21306407 DOI: 10.1111/ j.1365-2036.2011.04590. x]
34. Mullen KD, Prakash RK. Future of Hepatic Encephalopathy. In: Mullen KD, Prakash RK, editors. Hepatic Encephalopathy. Berlin: Springer, 2012: 241-243
35. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dölle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981; 26: 622-630 [PMID: 7249898]
36. Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, Guarner C, Soriano G. Minimal hepatic encephalopathy is associated with falls. Am J Gastroenterol 2011; 106: 476-482 [PMID: 20978484 DOI: 10.1038/ajg.2010.413]
37. Córdoba J, Lucke R. Driving under the influence of minimal hepatic encephalopathy. Hepatology 2004; 39: 599-601 [PMID: 14999676]
38. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011; 106: 307-316 [PMID: 21157444 DOI: 10.1038/ajg.2010.455]
39. Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Fuchs M, Luketic V, Sanyal AJ. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011; 140: 478-487. e1 [PMID: 20849805 DOI: 10.1053/ j. gastro.2010.08.061]
40. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010; 7: 515-525 [PMID: 20703237 DOI: 10.1038/ nrgastro.2010.116]